4 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Prostate: new trials by email Literature Review of Prostate trials Research Report on Prostate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. Darolutamide, docetaxel, ADT - Prostate Cancer, Prostate | Phase 2 | Not yet recruiting | RenJi Hospital | 200 | 2026-08-01 | 2026-07-28 |
| POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions Flotufolastat F 18 - Prostate | Phase 2 | Recruiting | University of Florida | 30 | 2025-11-04 | 2026-04-13 |
| Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis Olaparib - Prostate | Phase 2 | Active not recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 51 | 2017-03-01 | 2026-05-12 |
| Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats olaparib - Ovarian, Breast | Phase 2 | Completed | AstraZeneca | 298 | 2010-02-21 | 2025-08-13 |
| Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems tadalafil, placebo - Prostatic Hyperplasia, Prostate | Phase 2 | Completed | Eli Lilly and Company | 275 | 2004-10-01 | 2007-10-22 |
| Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle GnRH, Ketoconazole, Bicalutamide - Prostate, Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 36 | 2001-07-01 | 2016-03-25 |
| Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer QS21 - Prostate, Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 30 | 2000-11-01 | 2023-10-05 |
Neoplasms (2) · Prostatic Neoplasms (2) · Prostatic Hyperplasia (1)
Genital Diseases (3) · Genital Diseases, Male (3) · Male Urogenital Diseases (3) · Prostatic Diseases (3) · Urogenital Diseases (3) · Genital Neoplasms, Male (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Neoplasms (2)
olaparib (2) · Docetaxel (1) · Estradiol (1) · Gonadotropin-Releasing Hormone (1) · Goserelin (1) · Ketoconazole (1) · Leuprolide (1) · Tadalafil (1) · Testosterone (1) · bicalutamide (1) · darolutamide (1) · saponin QA-21V1 (1)
Memorial Sloan Kettering Cancer Center (2) · AstraZeneca (1) · Eli Lilly and Company (1) · RenJi Hospital (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of Florida (1)
United States (6) · Australia (1) · Germany (1) · Israel (1) · Spain (1) · Sweden (1)
Bella Kaufman, MD (1) · Catherine H Marshall, MD (1) · Howard Scher, MD (1) · Jane Robertson, BSc, MBCHB, MD (1) · Susan Slovin, MD, PhD (1)